Drugs / TK99UN
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00844623 | Dec 2002 → Nov 2003 | hepatocellular carcinoma | Clinica Universidad de Navarra, Universidad de Navarra | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TK99UN | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00844623 ↗ |
| Known as | Ad.TK | “The aim of this phase I clinical trial was to assess the feasibility and safety of intratumoral administration of a first-generation adenoviral vector encoding herpes simplex...” PMID 20689572 ↗ Aug 2010 |